Natera Gains Medicare Coverage for Signatera Liver Cancer Testing

Medicare coverage now includes serial Signatera testing for surveillance of early-stage hepatocellular carcinoma patients with no post-surgical evidence of disease. The decision was supported by a 125-patient real-world study.